WHO Quality of Life Scale

Abstract

The World Health Organization Quality of Life HIV Instrument, abbreviated as the WHOQOL-HIV BREF, is an internationally standardized, culturally adapted, patient-reported outcome measure designed to quantify the multidimensional subjective well-being and health-related quality of life of persons living with HIV/AIDS (PLWHA). Derived from the comprehensive 120-item WHOQOL-HIV instrument and the generic WHOQOL-BREF, this 31-item abbreviated instrument assesses six distinct yet interrelated domains: Physical Health (4 items), Psychological Health (5 items), Level of Independence (4 items), Social Relationships (4 items), Environment (8 items), and Spirituality, Religion, and Personal Beliefs (SRPB) (4 items), alongside two global benchmark items evaluating general quality of life and subjective health perception. Items are calibrated across a 5-point Likert response scale capturing intensity, capacity, frequency, or evaluation over a 2-week retrospective recall frame.

Extensive international psychometric validation studies across culturally diverse cohorts—including low-, middle-, and high-income countries—demonstrate that the WHOQOL-HIV BREF possesses robust structural, convergent, and discriminant validity. Confirmatory factor analyses consistently substantiate the six-domain structural topology over alternative four-factor generic formulations, reflecting the unique biopsychosocial stressors experienced by PLWHA, such as HIV-related stigma, discrimination, bodily changes, and existential mortality concerns. Internal consistency reliability coefficients (Cronbach’s alpha) generally exceed .70 across all domains, frequently spanning .75 to .88, while test-retest reliability across 2-to-4-week intervals reveals intraclass correlation coefficients ranging from .72 to .89. The instrument provides a clinically responsive, epidemiologically sound, and cross-culturally invariant metric for monitoring disease progression, evaluating antiretroviral therapy (ART) regimens, and appraising psychosocial interventions.

Keywords

WHOQOL-HIV BREF, Quality of Life, HIV/AIDS, Psychometrics, Patient-Reported Outcome Measures (PROMs), Health-Related Quality of Life (HRQoL), Cross-Cultural Assessment, Spirituality Religion and Personal Beliefs, Stigma, Antiretroviral Therapy.

Authors

The WHOQOL-HIV BREF was developed under the auspices of the World Health Organization Quality of Life (WHOQOL) Group, coordinated by the Department of Mental Health and Substance Dependence at the World Health Organization in Geneva, Switzerland. Key coordinating investigators and psychometricians instrumental in its formulation, adaptation, and field testing include:

• Dr. Shekhar Saxena — Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
• Prof. Suzanne M. Skevington — International Centre for Health and Society, Department of Psychology, University of Bath, and WHO Centre for the Study of Quality of Life, University of Manchester, United Kingdom.
• Prof. Kathryn A. O’Connell — Division of Mental Health, World Health Organization, Geneva, Switzerland.
• Prof. Donald L. Patrick — Department of Health Services, University of Washington, Seattle, Washington, United States.
• Prof. Mick Power — Department of Clinical Psychology, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, United Kingdom.
• Collaborating International Field Centers — Investigators across field validation centers in Australia, Brazil, China, India, Italy, South Africa, Thailand, the United Kingdom, and the United States.

Institutional Contact: Department of Mental Health and Substance Use, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. Web portal: WHO Mental Health and Substance Use.

Purpose

The historical trajectory of human immunodeficiency virus (HIV) medicine has evolved from an acute, terminal infectious disease management paradigm into a chronic disease management model, largely driven by the advent of potent combination antiretroviral therapy (cART). As therapeutic interventions successfully suppressed viral replication and extended life expectancy, traditional biomedical metrics—such as CD4+ T-lymphocyte counts and plasma HIV-1 RNA viral loads—proved insufficient for capturing the total disease burden experienced by persons living with HIV/AIDS. Chronic survivorship introduced complex secondary challenges, including lifelong medication adherence, drug-induced adverse metabolic effects (e.g., lipodystrophy), persistent neurocognitive disturbances, social ostracism, internalized stigma, and existential distress regarding illness progression and death. Consequently, the development of the WHOQOL-HIV instrument was initiated to capture the broader, subjective lived experiences of individuals navigating HIV within distinct cultural ecosystems.

The primary clinical and research objectives of the WHOQOL-HIV BREF are threefold:

• Holistic Clinical Evaluation: To serve as a diagnostic and monitoring tool within routine clinical consultations, enabling healthcare providers to identify non-biological drivers of distress, functional impairment, or poor adherence that biomedical laboratory tests fail to illuminate.
• Programmatic and Clinical Trial Evaluation: To function as a sensitive patient-reported outcome measure (PROM) in randomized controlled trials (RCTs) assessing pharmacological therapies, psychotherapy, peer support initiatives, and socio-economic support programs targeted at PLWHA.
• Epidemiological and Health Systems Surveillance: To furnish national and global public health institutions with cross-nationally comparable data to evaluate health disparities, allocate resources, and assess the broader societal determinants of health impacting marginalized populations living with HIV.

By shortening the parent 120-item WHOQOL-HIV down to a 31-item brief inventory, the instrument drastically reduces respondent burden, rendering it exceptionally suitable for acutely ill patients, individuals experiencing severe fatigue, or resource-constrained clinical settings where administration time is severely constrained.

Psychological Construct

The WHOQOL-HIV BREF conceptualizes quality of life not merely as the absence of disease or functional infirmity, but rather as an individual’s subjective perception of their position in life within the context of the culture and value systems in which they live, and in relation to their goals, expectations, standards, and concerns. This definition anchors quality of life as an intrinsically subjective, multidimensional, and culturally embedded construct. The scale operationalizes this theoretical definition through six primary domains and one general facet:

1. Domain I: Physical Health (4 Items)

This domain captures the physical compromises imposed by the retroviral infection and its treatments. It encompasses bodily pain and discomfort (Item 3), energy and vitality versus chronic fatigue (Item 14), restorative sleep and rest architecture (Item 21), and the specific disruptive burden of HIV symptoms (Item 4). The physical construct reflects both somatic pathology and the physical distress associated with pharmaceutical side effects (such as neuropathy, nausea, or metabolic disruptions).

2. Domain II: Psychological Health (5 Items)

The psychological domain evaluates affective equilibrium, cognitive integrity, and self-appraisal. It assesses the presence of positive feelings such as joy and satisfaction (Item 6), cognitive faculties including memory, learning capacity, and concentration (Item 11), self-esteem and self-worth (Item 24), body image and acceptance of physical appearance (Item 15)—a facet especially salient given HIV-associated wasting and lipodystrophic changes—and the frequency of debilitating negative affective states such as despair, anxiety, and depression (Item 31).

3. Domain III: Level of Independence (4 Items)

Reflecting personal autonomy, this domain evaluates functional capacity across routine motor and socio-occupational tasks. It captures functional mobility and the capacity to get around (Item 20), competence in performing basic activities of daily living (ADL) such as dressing and hygiene (Item 22), occupational capacity and the ability to maintain employment (Item 23), and the psychological and physical burden of daily dependence on medical treatment and medications to sustain routine functioning (Item 5).

4. Domain IV: Social Relationships (4 Items)

Interpersonal connectivity constitutes a foundational determinant of survival and well-being in chronic illness. This domain captures the degree of satisfaction with personal interpersonal relationships (Item 25), social support received from friends and social networks (Item 27), sexual health and satisfaction with sex life (Item 26)—frequently disrupted by fears of transmission, stigma, or physiological dysfunction—and the extent to which the individual feels integrated and accepted by their acquaintances (Item 17).

5. Domain V: Environment (8 Items)

Recognizing the powerful socio-ecological determinants of health, this expansive domain measures an individual’s external living reality. It encompasses feelings of physical safety and security (Item 12), physical environmental quality regarding pollution, noise, and climate (Item 13), financial adequacy to meet basic survival and lifestyle needs (Item 16), accessibility of essential day-to-day information (Item 18), opportunities for recreational and leisure activities (Item 19), adequacy of housing conditions (Item 28), equitable access to physical health services (Item 29), and adequacy of transportation systems (Item 30).

6. Domain VI: Spirituality, Religion, and Personal Beliefs (SRPB) (4 Items)

Unlike standard generic instruments that omit or marginalize existential health, the WHOQOL-HIV BREF explicitly includes an expanded SRPB domain tailored to the unique existential crises provoked by HIV infection. This dimension evaluates the perception of life meaning and purpose (Item 7), the psychological toll of social blame and discrimination stemming from one’s HIV diagnosis (Item 8), anticipatory anxiety and fear regarding future decline (Item 9), and existential terror or apprehension surrounding death and dying (Item 10).

7. Overall Quality of Life and General Health Perceptions (2 Items)

Items 1 and 2 operate as global benchmarks assessing self-rated overall quality of life and subjective health satisfaction, respectively. These items provide overarching anchors that synthesize the respondent’s holistic evaluation independent of specific domain partitions.

Theoretical Framework

The theoretical architecture of the WHOQOL-HIV BREF is grounded in the foundational World Health Organization (1948) constitution, which defines health as “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.” Psychologically and epistemologically, the instrument synthesizes three core conceptual models:

1. The Biopsychosocial Model

Formulated by George Engel, the biopsychosocial model posits that biological, psychological, and social factors exist in continuous, dynamic, non-linear reciprocity. The WHOQOL-HIV operationalizes this paradigm by rejecting biological reductionism. HIV infection cannot be understood solely as retroviral cellular destruction; it must be conceptualized as a biological phenomenon intertwined with psychological processes (depression, demoralization, resilience) and structural environmental realities (poverty, healthcare access, social marginalization).

2. The Transactional Model of Stress and Coping

Drawing on Richard Lazarus and Susan Folkman’s transactional model, health-related quality of life is theorized as the downstream outcome of continuous cognitive appraisal. Living with HIV constitutes an ongoing chronic stressor characterized by unpredictable disease trajectories, potential physical deterioration, and profound socio-moral threats. An individual’s quality of life depends on primary appraisal (evaluating HIV-related threats to mortality, physical appearance, and social standing) and secondary appraisal (evaluating personal coping resources, social support, and financial resources). Items evaluating future fear, bodily acceptance, and medical dependency directly reflect these stress-appraisal equilibria.

3. Syndemics Theory and Cultural Universalism

In accordance with Singer’s syndemics theory, HIV frequently co-occurs and synergistically interacts with structural violence, poverty, discrimination, and mental health morbidity. The development of the WHOQOL instruments was explicitly designed to achieve cross-cultural universalism without succumbing to Eurocentric or Western-centric conceptual biases. Rather than developing an instrument in one country and translating it linguistically, the WHOQOL Group employed a collaborative simultaneous development protocol across 15 global centers worldwide. Focus groups comprising patients, healthcare professionals, and family caregivers in disparate cultural, economic, and geographic contexts established a shared conceptualization of quality of life, ensuring that the latent constructs evaluated by the WHOQOL-HIV BREF possess cross-cultural conceptual equivalence.

Validity

The psychometric validity of the WHOQOL-HIV BREF has been extensively investigated and confirmed across hundreds of empirical studies spanning Africa, Asia, Europe, North America, and South America. The evidence demonstrates high construct, convergent, discriminant, and criterion-related validity.

Construct and Structural Validity

Structural validity has been corroborated through structural equation modeling (SEM) and confirmatory factor analysis (CFA). In multi-center international investigations (e.g., O’Connell et al., 2003; Fang et al., 2002; Starace et al., 2002), the six-domain model demonstrated significantly superior fit compared to single-factor or generic four-domain models. The fit indices consistently satisfy rigorous psychometric criteria (e.g., Comparative Fit Index [CFI] > .90; Tucker-Lewis Index [TLI] > .90; Root Mean Square Error of Approximation [RMSEA] < .06; Standardized Root Mean Square Residual [SRMR] < .05).

Convergent and Concurrent Validity

Convergent validity is documented via strong, statistically significant correlations with other validated psychometric scales and patient-reported outcome measures. Specifically:

• Physical and Independence Domains: Demonstrate strong positive correlations (r = .60 to .78) with physical functioning and role-physical scales of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the SF-36 Health Survey.
• Psychological Domain: Exhibits strong inverse correlations with standardized depressive symptom inventories, including the Beck Depression Inventory (BDI-II; r = -.62 to -.74) and the Center for Epidemiologic Studies Depression Scale (CES-D; r = -.65 to -.76).
• SRPB Domain: Correlates positively with spiritual well-being scales, such as the Functional Assessment of Chronic Illness Therapy – Spiritual Well-Being (FACIT-Sp; r = .55 to .70) and personal resilience metrics.

Discriminant and Known-Groups Validity

The instrument displays exceptional discriminant capacity across clinically distinct subpopulations of PLWHA:

• Immunological and Virological Staging: Mean domain scores—particularly for Physical Health, Independence, and Psychological Health—differ significantly across CDC clinical staging categories (asymptomatic HIV, symptomatic non-AIDS, and clinical AIDS), as well as between patients with undetectable vs. detectable viral loads.
• CD4+ T-Cell Strata: Patients with CD4+ counts < 200 cells/μL consistently record significantly lower Physical and Independence scores (p < .001) compared to individuals with CD4+ counts ≥ 500 cells/μL.
• Symptom Burden: Individuals experiencing adverse drug events or opportunistic infections demonstrate marked, statistically significant reductions in Domain 1 (Physical) and Domain 3 (Independence) compared to their asymptomatic peers.

Reliability

The reliability of the WHOQOL-HIV BREF has been comprehensively demonstrated across diverse language translations and clinical contexts through internal consistency metrics and temporal stability assessments.

Internal Consistency Reliability

Across validation cohorts internationally, the internal consistency of the six domains meets or exceeds the conventional .70 psychometric threshold for group comparisons, with several domains consistently reaching levels acceptable for individual clinical tracking (> .80):

• Physical Domain (4 items): Cronbach’s α typically ranges between .72 and .84.
• Psychological Domain (5 items): Cronbach’s α typically ranges between .75 and .86.
• Level of Independence (4 items): Cronbach’s α typically ranges between .73 and .83.
• Social Relationships (4 items): Cronbach’s α typically ranges between .68 and .81 (slight fluctuations occasionally observed due to the broad breadth of social and sexual facets).
• Environment (8 items): Cronbach’s α typically ranges between .80 and .89, demonstrating exceptional internal cohesion across external resource items.
• Spirituality, Religion, and Personal Beliefs (4 items): Cronbach’s α typically ranges between .70 and .82.

Test-Retest Temporal Stability

In stable clinical cohorts evaluated over 2-week to 4-week retest intervals, the instrument demonstrates substantial reproducibility. Intraclass correlation coefficients (ICC) across all six domains consistently range from .72 to .91, indicating minimal measurement error in the absence of acute clinical or life events. Pearson product-moment correlation coefficients for test-retest reliability across international validation trials similarly remain high (r > .75).

Measurement Precision and Standard Error

The standard error of measurement (SEM) across domains is minimal, supporting the scale’s sensitivity to detect subtle yet clinically meaningful intra-individual changes over time. Analysis of floor and ceiling effects indicates that fewer than 5% of respondents register minimum or maximum possible domain scores, confirming strong discriminative capacity across the full spectrum of illness severity.

Factor Analysis

The underlying dimensionality of the WHOQOL-HIV BREF was established via rigorous exploratory factor analysis (EFA) and confirmed through multigroup confirmatory factor analysis (CFA). During initial instrument development, EFA on international pooled samples extracted six principal components that aligned precisely with the theoretical domain structure, explaining upwards of 58% to 65% of the total variance across datasets.

Confirmatory Factor Structure

In structural equation modeling frameworks, the 31 items map onto the 6 latent constructs, with two general items (Q1 and Q2) loading directly onto a higher-order general quality of life construct or evaluated as standalone manifest indicators. The empirically verified factor loadings (λ) for the items onto their respective latent domain factors across major international validation studies (e.g., O’Connell et al., 2003; Chandra et al., 2006; Saddki et al., 2009) are summarized below:

• Physical Domain: Pain (Q3: λ = .64 to .78), Symptoms (Q4: λ = .61 to .75), Energy (Q14: λ = .68 to .82), Sleep (Q21: λ = .55 to .71).
• Psychological Domain: Enjoyment (Q6: λ = .69 to .84), Concentration (Q11: λ = .58 to .73), Bodily image (Q15: λ = .52 to .68), Self-satisfaction (Q24: λ = .72 to .85), Negative feelings (Q31: λ = .60 to .76).
• Level of Independence Domain: Medical dependence (Q5: λ = .50 to .66), Mobility (Q20: λ = .65 to .79), ADL (Q22: λ = .74 to .88), Work capacity (Q23: λ = .70 to .84).
• Social Relationships Domain: Social acceptance (Q17: λ = .58 to .74), Personal relationships (Q25: λ = .70 to .83), Sex life (Q26: λ = .56 to .72), Social support (Q27: λ = .66 to .80).
• Environment Domain: Safety (Q12: λ = .62 to .76), Physical environment (Q13: λ = .64 to .77), Financial resources (Q16: λ = .55 to .70), Information availability (Q18: λ = .60 to .74), Leisure opportunity (Q19: λ = .63 to .78), Home environment (Q28: λ = .68 to .82), Health access (Q29: λ = .59 to .73), Transport (Q30: λ = .54 to .71).
• Spirituality/Religion/Personal Beliefs Domain: Meaningful life (Q7: λ = .66 to .81), Blame (Q8: λ = .51 to .67), Fear of future (Q9: λ = .68 to .82), Death anxiety (Q10: λ = .60 to .77).

Measurement Invariance

Multi-group CFA studies have established configural, metric, and scalar measurement invariance across genders, age groups, and diverse international populations. This structural stability confirms that cross-national differences in domain scores reflect genuine substantive variations in quality of life rather than psychometric measurement artifacts.

Instrument / Measurement Tool

The WHOQOL-HIV BREF is structured as follows:

• Test Type: Multi-dimensional Patient-Reported Outcome Measure (PROM) / Self-report questionnaire (interviewer-administered formats are permitted for individuals with low literacy).
• Number of Items: 31 items total (2 general benchmark items + 29 domain-specific items).
• Recall Period: Past two weeks (“in the last two weeks”).
• Response Format: 5-point Likert scale (rated 1 to 5), utilizing standardized response anchors assessing intensity, capacity, frequency, or subjective satisfaction.
• Administration Time: Approximately 8 to 12 minutes.
• Reverse-Coded Items: Five negative items require reverse coding (subtracting the raw score from 6) prior to domain aggregation so that higher scores consistently reflect better quality of life:
• Item 3: Physical pain (6 – Q3)
• Item 4: Bothered by HIV physical problems (6 – Q4)
• Item 5: Medical treatment dependency (6 – Q5)
• Item 8: Bothered by people blaming for HIV status (6 – Q8)
• Item 9: Fear of the future (6 – Q9)
• Item 10: Worry about death (6 – Q10)
• Item 31: Frequency of negative feelings (6 – Q31)
• Domain Scoring Formulas: The raw scores within each domain are summed and transformed. The WHO scoring manual specifies computing the mean of the domain items and multiplying by 4, producing scores ranging from 4 to 20 (comparable to the original WHOQOL-100 scale), or linearly transforming domain scores to a 0–100 scale:
• Domain 1 (Physical): Raw = (6 – Q3) + (6 – Q4) + Q14 + Q21 → Mean × 4
• Domain 2 (Psychological): Raw = Q6 + Q11 + Q15 + Q24 + (6 – Q31) → Mean × 4
• Domain 3 (Level of Independence): Raw = (6 – Q5) + Q20 + Q22 + Q23 → Mean × 4
• Domain 4 (Social Relationships): Raw = Q17 + Q25 + Q26 + Q27 → Mean × 4
• Domain 5 (Environment): Raw = Q12 + Q13 + Q16 + Q18 + Q19 + Q28 + Q29 + Q30 → Mean × 4
• Domain 6 (SRPB): Raw = Q7 + (6 – Q8) + (6 – Q9) + (6 – Q10) → Mean × 4
• Linear Transformation to 0–100 Scale: Domain Score (0–100) = [(Mean Domain Score − 4) / 16] × 100.
• Missing Data Rule: If more than 20% of the items within a domain are missing, the domain score should not be calculated. If 1 item is missing in a 4-item or 5-item domain (or ≤ 2 items in the 8-item Environment domain), the mean of the remaining completed items in that specific domain substitutes for the missing value.

Permissions & Fee and Test Year

The WHOQOL-HIV instrument was initially drafted and field-tested in the late 1990s and formally disseminated in 2002, with revised psychometric manuals and scoring protocols published by the World Health Organization in 2012.

Licensing and Accessibility: The World Health Organization maintains copyright over the instrument to preserve its integrity and psychometric standardization. However, the WHOQOL-HIV BREF is open access and free of charge for non-commercial academic research, clinical practice, public health surveillance, and educational initiatives. Researchers and non-commercial entities must register and request user permission via the formal WHO Quality of Life questionnaire request portal or by contacting the WHO Department of Mental Health and Substance Use. Commercial entities, pharmaceutical clinical trials, or sponsored corporate studies require formal written licensing agreements and may incur licensing administrative fees. Official translations are available in dozens of languages through authorized national WHO collaborating centers.

References

Bonomi, A. E., Patrick, D. L., Bushnell, D. M., & Martin, M. (2000). Validation of the United States’ version of the World Health Organization Quality of Life (WHOQOL) instrument. Journal of Clinical Epidemiology, 53(1), 1–12. https://doi.org/10.1016/S0895-4356(99)00123-7

Chandra, P. S., Gandhi, C., Satishchandra, P., Kamat, V. D., Desai, A., & Ravi, V. (2006). Quality of life in HIV/AIDS: A study from South India using the WHOQOL-HIV-BREF. AIDS Care, 18(4), 328–335. https://doi.org/10.1080/09540120500161860

Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460

Fang, C. T., Hsiung, P. C., Yu, C. F., Chen, M. Y., & Wang, J. D. (2002). Validation of the World Health Organization Quality of Life (WHOQOL)-BREF instrument in patients with HIV infection in Taiwan. Quality of Life Research, 11(3), 255–265. https://doi.org/10.1023/a:1015248408354

McDowell, I. (2006). Measuring health: A guide to rating scales and questionnaires (3rd ed.). Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195165678.001.0001

O’Connell, K. A., Saxena, S., & Skevington, S. M. (2004). WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: Results from the field test. AIDS Care, 16(7), 882–889. https://doi.org/10.1080/09540120412331290194

Peltzer, K., & Phaswana-Mafuya, N. (2008). Depression and quality of life among people living with HIV/AIDS in South Africa. Social Behavior and Personality: An International Journal, 36(2), 187–198. https://doi.org/10.2224/sbp.2008.36.2.187

Saddki, N., Noor, N. M., Mohamad, S., & Mokhtar, N. (2009). Validity and reliability of the Malay version of WHOQOL-HIV BREF. Health and Quality of Life Outcomes, 7(1), Article 87. https://doi.org/10.1186/1477-7525-7-87

Skevington, S. M., Bradshaw, J., & Saxena, S. (1999). Selecting national items for the WHOQOL: Conceptual and psychometric considerations. Social Science & Medicine, 48(4), 473–487. https://doi.org/10.1016/S0277-9536(98)00366-0

Starace, F., Cafaro, E., Abrescia, N., Chirianni, A., Izzo, C., Piazza, M., & Soscia, M. (2002). Validation of the Italian version of the WHOQOL-HIV: A quality of life instrument for people with HIV/AIDS. Quality of Life Research, 11(7), 657–658. https://doi.org/10.1023/A:1020351322079

WHOQOL Group. (1993). Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153–159. https://doi.org/10.1007/BF00435734

WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558. https://doi.org/10.1017/s0033291798006667

World Health Organization. (2012). WHOQOL-HIV BREF: Introduction, administration, scoring and generic version of the assessment (Field Test Version, Rev. 2012.02). World Health Organization. http://apps.who.int/iris/bitstream/10665/77775/1/WHO_MSD_MER_Rev.2012.02_eng.pdf

13. Items of the Scale (Questionnaire)